Syngene International Limited
SYNGENE · 539268 · Healthcare · Healthcare Research, Analytics & Technology
Rs 401.45+0.15 (+0.04%)
- Market cap
- Rs 16,174 Cr
- P/E
- 50.95x
- P/B
- 3.34x
- 52W high / low
- Rs 684.6 / Rs 375.25
Our computed operating_margin (12.30%) diverges from BSE's own published figure (31.09%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
More
Peer comparison
Official BSE basic industry: Healthcare Research, Analytics & Technology. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Syngene International LimitedThis company | Rs 401.45 | Rs 16,174 Cr | Rs 3,809 Cr | Rs 317 Cr | 50.95x | 6.62% |
| Indegene Limited | Rs 555.8 | Rs 13,367 Cr | Rs 3,892 Cr | Rs 401 Cr | 33.26x | 10.39% |
| Suven Life Sciences Limited | Rs 342.35 | Rs 9,038 Cr | Rs 29.7 Cr | Rs -352.4 Cr | — | -100.50% |
| Median | Rs 555.8 | Rs 13,367 Cr | Rs 3,892 Cr | Rs 401 Cr | 33.26x | 10.39% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.
Loading stock details